GCG and obesity due to melanocortin 4 receptor deficiency: Even if the precise mechanisms involved in the insulin-releasing action of glicentin remains to be elucidated, these results pinpoint the potential interest of glicentin as marker and/or player of metabolic diseases such as diabetes or obesity.